Francis Boateng

Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial.

R. Wunderink, M. Niederman, B. Cao, 2019, The Lancet. Infectious diseases.

Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study.

H. Collard, F. Martinez, S. Nathan, 2019, The Lancet. Respiratory medicine.

Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction: A Phase IIb Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Hemodynamic Study

H. Ghofrani, S. Felix, Lothar Roessig, 2013, Circulation.

The Combined Effect of Nursing Support and Adverse Event Mitigation on Adherence to Interferon Beta-1b Therapy in Early Multiple Sclerosis: The START Study.

S. Dhib-jalbut, C. Markowitz, Francis Boateng, 2012, International journal of MS care.

Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.

R. Mandler, S. Lynch, D. Jeffery, 2008, Clinical therapeutics.

Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.

R. Mandler, S. Lynch, D. Jeffery, 2008, Clinical therapeutics.